BDARIB RUCAPARIB TABLETS

Get a Price/Quote

MOQ : 1 Bottle

BDARIB RUCAPARIB TABLETS Specification

Indication
Ovarian Cancer and Prostate Cancer

Dosage Form
Tablet

Salt Composition
Rucaparib

Enzyme Types
PARP Inhibitor

Feature
High efficacy, oral administration

Ingredients
Rucaparib Camsylate, Excipients

Application
Anticancer Therapy

Ph Level
Neutral (approx. 7)

Physical Color/Texture
Film-coated Tablet, Pale Yellow

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits Poly (ADP-ribose) Polymerase

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 Months

BDARIB RUCAPARIB TABLETS Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 60 TABLETS

About BDARIB RUCAPARIB TABLETS

Get It Now: BDARIB RUCAPARIB TABLETS 300 mgan immaculate, kingly solution in modern oncology. Favorable reviews underscore its potent efficacy as a PARP inhibitor, approved by the US FDA for targeted anticancer therapy. Specially designed for oral administration, each pale yellow film-coated tablet offers unparalleled quality for ovarian and prostate cancer treatment. The blister-packed, odorless formula minimizes degradation and supports a stable shelf life of 24 months. Ephemeral side effects and hypersensitivity contraindications are clearly indicated. Prescription required. Store below 30C, away from moisture and light.

Comprehensive Oral Anticancer Therapy

BDARIB RUCAPARIB TABLETS are intended for prescription use as a robust and targeted oral treatment. Specially formulated for adults, it is utilized for combating ovarian and prostate cancer. With its potent PARP inhibition, it addresses specific genetic malignancies and shows consistent clinical results. The convenient once-daily oral route enhances patient compliance and makes it a preferred choice in tailored anticancer therapy.

Secure Payment and Swift Delivery Solutions

Efficient exchange and payment terms are designed for seamless acquisition. Orders are processed with reliability, ensuring delivery within scheduled timelines. As a leading distributor, exporter, and wholesaler in India, BDARIB guarantees all products are delivered securely and promptly to client destinations. The main export markets include Asia, the Middle East, and Eastern Europe. Customers can trust in a hassle-free transaction and tracking process for every delivered order.

FAQs of BDARIB RUCAPARIB TABLETS:

Q: How should BDARIB RUCAPARIB TABLETS be stored?

A: Store BDARIB RUCAPARIB TABLETS below 30C, protected from moisture and light, and always keep them in their original blister packaging until use.

Q: What are the main indications for using BDARIB RUCAPARIB TABLETS?

A: BDARIB RUCAPARIB TABLETS are primarily indicated for the treatment of ovarian cancer and prostate cancer in adult patients.

Q: When will my order for BDARIB RUCAPARIB TABLETS be delivered?

A: Delivery times depend on your location and chosen shipping options, but orders are typically processed swiftly to ensure prompt arrival to your address.

Q: Where can BDARIB RUCAPARIB TABLETS be supplied or exported?

A: These tablets are distributed and exported mainly to markets across Asia, the Middle East, and Eastern Europe by BDARIB as a trusted supplier and trader.

Q: What benefit does the PARP inhibitor activity provide?

A: The PARP inhibitor activity of BDARIB RUCAPARIB TABLETS helps to interrupt cancer cell repair mechanisms, increasing their susceptibility to anticancer therapy while sparing healthy cells.

Q: How can I verify the batch and expiry details for these tablets?

A: Batch numbers, manufacture dates, and expiry details are printed clearly on the packaging and carton for every box, ensuring traceability and product integrity.

Tell us about your requirement